War on Pharma

What's new on the Web

• 23 May – Trans-Pacific Partnership: Trade Agreement or Anti-China Alliance?
• 22 May – WHO: Concerns over draft text on R&D financing and coordination
• 22 May – The Transatlantic Free Trade Agreement: It’s About the Big Picture
• 21 May – TRIPping Up Least Developed Countries on Medicines, Green Tech, and Textbooks?
• 21 May – Live from the Trans Pacific Partnership: IP Chapter Shows No Sign of Resolution, End of Negotiation in 2013 Highly Unlikely
• 21 May – TRIPS Exemption Opposed By Obama Administration, Threatening Cost Spike For Drugs In Poorest Nations
• 21 May – Open Letter to TRIPS Council Chairman on LDC Extension: Alfredo Suescum, Ambassador of Panama to the World Trade Organization (WTO)
• 21 May – Trans Pacific Partnership Negotiations and the Controversial Issue of Pharmaceutical Test Data Protection
• 21 May – India-EU FTA talks fail to bridge gaps; ministerial meet unlikely
• 21 May – A victory for global public health in the Indian, Ellen T Hoen
• 17 May – India-EU FTA: Top officials hold second round of talks
• 16 May – India: Patents and precedents
• 16 May – Court ruling over privileged access for business in EU-India free trade talks
• 16 May – Angelina’s breast surgery possible in India, but there’s a catch
• 16 May – Countries must fix critical access to medicines flaws in Trans-Pacific Trade Pact
• 16 May – Political opposition to EU-India FTA gathers momentum
• 16 May – EU Trade Talks on ‘Last Lap’: India Commerce Minister
• 16 May – India-EU FTA talks stuck; insurance could be game spoiler
• 16 May – How Drug Companies Keep Medicine Out of Reach
• 15 May – Lives versus Profits
• 15 May – Angelina Jolie BRCA1 Mutation: Why Is the Breast Cancer Test At the Center Of a Supreme Court Battle?
• 15 May – Lobby fears norms violation in Cipla’s biosimilar drug
• 15 May – Internet advocates say the TPP is the biggest threat yet to open web
• 15 May – India talks tough on FTA with EU; asks for lowering ambition
• 15 May – India-EU trade negotiators prepare for crucial meet in Brussels
• 15 May – Mercedes contradicts SIAM’s stand on India-EU FTA
• 15 May – US keenly watching Indian moves on compulsory licensing in pharma sector
• 15 May – Govt reviewing impact of existing FTAs: Minister
• 15 May – ‘India, EU yet to reach consensus on vexed issues for FTA’
• 15 May – Allow TRIPS waiver for LDCs until they are developed
• 13 May – Senators Back 12-Year Data Exclusivity Period for Biosimilars and President Obama (Once Again) Does Not
• 13 May – Canada-EU trade talks hung up on beef market access issue
• 13 May – India-EU FTA: Final position yet to emerge on auto
• 13 May – India-EU ministers to meet only after concrete deliverables
• 10 May – CommonDreams: Why the TransPacific Partnership is a Scary Big (Trade) Deal
• 10 May – 16 economies to kick off Asian FTA negotiations Thursday
• 10 May – ASEAN+6 start regional FTA talks
• 9 May – India threatens to stall trade talks with EU
• 9 May – ‘India, EU yet to reach consensus on vexed issues for FTA’
• 9 May – Japanese Movement Against TPP Growing
• 9 May – India to gain more from FTAs in long term: Rao
• 9 May – India-EU FTA talks likely to hit roadblock
• 8 May – Don’t link compulsory licensing with price: Pharma companies
• 8 May – Parliament logjam casts shadow over India-EU FTA
• 7 May – Investors’ IP Rights Unbound: The Danger of Investment Clauses to Access to Medicines
• 6 May – How Big Pharma Is Killing Americans
• 6 May – A treaty too many
• 6 May – Thailand remains on ‘dirty dozen’ list
• 6 May – PhRMA press release on the Special 301 Report
• 6 May – India, European Union may skirt thorny Issues, ink FTA
• 6 May – Oppn wants FTA with EU to be discussed in parliament
• 6 May – India should seek consolidation of FTAs: ADB
• 2 May – US Special 301 report 2013: India on priority watch list again
• 1 May – Negotiating a sell-out?
• 1 May – License for Manufacturing Generic Anti-Cancer Drugs
• 1 May – Latin American states form alliance to tackle investment treaties
• 30 April – US and EU demand TRIPS plus concession from poorest countries
• 30 April – US and EU demand TRIPS plus concession from poorest countries
• 30 April – Global Academics’ Expert Letter on LDCs’ TRIPS Extension Request
• 30 April – Global Academics’ Expert Letter on LDCs’ TRIPS Extension Request